- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Gwreiddiol (a wnaed Fel)
Dyma’r fersiwn wreiddiol (fel y’i gwnaed yn wreiddiol). Dim ond ar ei ffurf wreiddiol y mae’r eitem hon o ddeddfwriaeth ar gael ar hyn o bryd.
Statutory Instruments
Dangerous Drugs
Made
21st February 2024
Coming into force
20th March 2024
At the Court at Buckingham Palace, the 21st day of February 2024
Present,
The King’s Most Excellent Majesty in Council
In accordance with section 2(5) of the Misuse of Drugs Act 1971(1), a draft of this Order has been laid before Parliament after consultation with the Advisory Council on the Misuse of Drugs and approved by a resolution of each House of Parliament.
Accordingly, His Majesty, in exercise of the powers conferred on Him by section 2(2) of that Act, is pleased, by and with the advice of His Privy Council, to order, and it is hereby ordered, as follows:
1.—(1) This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) Order 2024 and comes into force on the twenty-eighth day after the day on which it is made.
(2) This Order extends to England and Wales, Scotland and Northern Ireland.
2.—(1) The following amendments are made to Schedule 2 to the Misuse of Drugs Act 1971.
(2) In Part 1 (which specifies the drugs which are subject to control as Class A drugs)(2) in paragraph 1(a)—
(a)after “Bezitramide.” insert “Brorphine.”;
(b)after “Bufotenine.” insert “Butonitazene.”;
(c)after “Ecgonine, and any derivate of ecgonine which is convertible to ecgonine or to cocaine.” insert “Ethyleneoxynitazene.”;
(d)after “Eticyclidine.” insert “Etodesnitazene (etazene).”;
(e)after “Fentanyl.” insert “Flunitazene.”;
(f)after “Isomethadone.” insert “Isotonitazene.”;
(g)after “Methyldihydromorphine (6-methyldihydromorphine).” insert—
“Metodesnitazene (metazene).
Metonitazene.”;
(h)after “Properidine (1-methyl-4-phenyl-piperdine-4-carboxylic acid isopropyl ester).” insert “Protonitazene.”;
(i)after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45).” insert—
“N-Desethyl etonitazene.
N-Desethylisotonitazene.
N-Desethyl protonitazene.”;
(j)after “4-Phenylpiperidine-4-carboxylic acid ethyl ester.” insert—
“N-Piperidinyl-etonitazene (etonitazepipne).
N-Pyrrolidino-etonitazene (etonitazepyne).
N-Pyrrolidino protonitazene.”.
(3) In Part 2 (which specifies the drugs which are subject to control as Class B drugs)(3) in paragraph 1(a)—
(a)after “Codeine.” insert “Cumyl-PeGaClone.”;
(b)after “Dihydrocodeine.” insert—
“Diphenidine.
Ephenidine.”;
(c)after “Methcathinone” insert “Methoxyphenidine.”.
(4) In Part 3 (which specifies the drugs which are subject to control as Class C drugs)(4) in paragraph 1(a) after “Pyrovalerone.” insert “Remimazolam.”.
Richard Tilbrook
Clerk of the Privy Council
(This note is not part of the Order)
This Order brings certain drugs under the control of the Misuse of Drugs Act 1971 (c. 38) (“the Act”). Article 2(2) of this Order brings fifteen synthetic opioids, including fourteen nitazenes, under control as Class A drugs under the Act. Article 2(3) of this Order brings cumyl-PeGaClone, diphenidine, ephenidine, and methoxyphenidine under control as Class B drugs under the Act. Article 2(4) of this Order brings remimazolam under control as a Class C drug under the Act.
A full impact assessment of the effect that this instrument will have on the costs of business, the voluntary sector and community bodies is available from www.legislation.gov.uk and published with an Explanatory Memorandum alongside the instrument. Copies may be obtained from the Drug Misuse Unit of the Home Office at 2 Marsham Street, London, SW1P 4DF.
Subparagraph (a) was designated as such by S.I. 1977/1243. Relevant amending instruments are S.I. 1984/859 and S.I. 2015/215. There are other amendments to Part 1 of Schedule 2 which are not relevant to this Order.
Subparagraph (a) of paragraph 1 was designated as such by S.I. 1984/859. A relevant amending instrument is S.I. 1998/750. There are other amendments to Part 2 of Schedule 2 which are not relevant to this Order.
Subparagraph (a) of paragraph 1 was designated as such by S.I. 1996/1300. A relevant amending instrument is S.I. 1986/2230. There are other amendments to Part 3 of Schedule 2 which are not relevant to this Order.
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys